Idun Pharmaceuticals
Pioneering therapeutic solutions to control apoptosis and advance treatments for liver disease, CNS disorders, inflammation, and cancer.
General Information
Get notified when Idun Pharmaceuticals moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Idun Pharmaceuticals
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
About Idun Pharmaceuticals
Taxonomy: Biopharmaceutical, Therapeutic Solutions, Apoptosis Management, Liver Disease Treatment, CNS Disorders, Inflammation Treatment, Cancer Treatment, Drug Development, Phase 2 Trials, Preclinical Trials, IDN-6556, Hepatitis C, San Diego, Conatus Pharmaceuticals, Subsidiary
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Debt Financing | •••••• | - | 13 Jul 2015 | |
| Venture Round | •••••• | - | 09 Feb 2015 | |
| Series B | •••••• | 9 |
|
15 Jun 2004 |
| Series A | •••••• | 1 |
|
09 Dec 2002 |
| Seed Round | •••••• | - | 01 Jan 1995 |
Idun Pharmaceuticals Alternatives & Competitors
Developing novel treatments of inflammatory diseases and cancer
Pioneering breakthroughs in genetic disorders and liver diseases using RNA interference technology.
Pioneering the future of tumor disease treatment through advanced pharmaceutical research and develo...
FAQ About Idun Pharmaceuticals
Don't just browse. Track.
Signal Tracker monitors Idun Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.